Rash Relief
NDC 15071-604
Product Information
Rash Relief is a OTC MONOGRAPH FINAL-approved product labeled by Touchless Care Concepts Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 15071-604 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 15071-604?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ZINC OXIDE (UNII: SOI2LOH54Z)
- ZINC OXIDE (UNII: SOI2LOH54Z) (Active Moiety)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- DIMETHICONE (UNII: 92RU3N3Y1O) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MINERAL OIL (UNII: T5L8T28FGP)
- CYCLOMETHICONE (UNII: NMQ347994Z)
- LANOLIN (UNII: 7EV65EAW6H)
- MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)
- HEXAMETHYLDISILOXANE (UNII: D7M4659BPU)
- WATER (UNII: 059QF0KO0R)
- CHOLECALCIFEROL (UNII: 1C6V77QF41)
- VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
- PETROLATUM (UNII: 4T6H12BN9U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1101350 - RASH RELIEF with ZINC OXIDE 20 % / 25 % Topical Spray
- RxCUI: 1101350 - dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray [Rash Relief with Zinc Oxide]
- RxCUI: 1101350 - dimethicone 200 MG/ML / ZNO 250 MG/ML Topical Spray [Rash Relief with Zinc Oxide]
- RxCUI: 1101350 - Rash Relief with Zinc Oxide (dimethicone 20 % / zinc oxide 25 % ) Topical Spray
- RxCUI: 968817 - dimethicone 20 % / zinc oxide 25 % Topical Spray
* Please review the full disclaimer at the bottom of this page.